Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 139th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
ERAS	ERASCA INC	$5.69B	-77.00%	-64.30%	-63.75%	-71.80%	0.17	9.52	N/A	N/A	N/A
SGP	SPYGLASS PHARMA INC	$831.18M	N/A	N/A	N/A	N/A	0.05	25.06	N/A	N/A	N/A
FRMM	FORUM MARKETS INC	$90.89M	-244.40%	-136.80%	-267.83%	-147.80%	0.23	6.19	100.00%	-5,575.30%	-5,532.18%
RLAY	RELAY THERAPEUTICS INC	$4.38B	-42.30%	-38.70%	-31.20%	-46.90%	0.09	18.27	100.00%	-2,763.60%	-2,763.64%
IMMX	IMMIX BIOPHARMA INC	$821.99M	-38.40%	-34.70%	-17.36%	-1,845.60%	0.05	25.13	N/A	N/A	N/A
KRRO	KORRO BIO INC	$196.15M	-114.30%	-68.60%	-70.15%	-69.50%	0.58	9.55	100.00%	-4,477.10%	-4,441.86%
DRTS	ALPHA TAU MEDICAL LTD	$1.32B	-138.10%	-81.70%	-107.57%	-125.50%	2.05	11.09	N/A	N/A	N/A
STRO	SUTRO BIOPHARMA INC	$414.92M	N/A	-69.20%	-89.49%	-154.30%	-4.62	3.12	100.00%	-154.20%	-153.78%
REPL	REPLIMUNE GROUP INC	$1.15B	-128.60%	-82.30%	-111.48%	-110.50%	1.00	4.79	N/A	N/A	N/A
CMND	CLEARMIND MEDICINE INC	$1.64M	-143.80%	-88.50%	-68.36%	694.30%	0.26	4.79	N/A	N/A	N/A
CNTB	CONNECT BIOPHARMA HOLDINGS LTD	$141.04M	-122.30%	-97.10%	-149.73%	-482.50%	0.41	3.23	100.00%	-27,727.90%	-27,645.92%
EIKN	EIKON THERAPEUTICS INC	$553.84M	N/A	N/A	N/A	N/A	0.55	11.75	N/A	N/A	N/A
ENTX	ENTERA BIO LTD	$519.43M	-147.20%	-103.20%	-98.22%	3,983.00%	1.68	8.98	N/A	N/A	N/A
RAPP	RAPPORT THERAPEUTICS INC	$2.34B	-29.00%	-27.40%	-31.86%	-36.00%	0.09	15.72	100.00%	-685.80%	-685.80%
GYRE	GYRE THERAPEUTICS INC	$740.43M	-17.70%	-10.80%	-8.18%	-12.90%	0.32	4.26	94.30%	-15.50%	-11.69%
HURA	TUHURA BIOSCIENCES INC	$146.47M	-154.00%	-105.40%	-128.06%	-867.00%	0.28	1.15	N/A	N/A	N/A
IVA	INVENTIVA SA	$912.08M	N/A	-192.20%	-79.70%	-87.70%	-9.75	3.16	100.00%	-4,468.10%	-1,730.94%
CLDI	CALIDI BIOTHERAPEUTICS INC	$1.98M	-575.70%	-239.20%	-327.35%	-970.30%	0.94	1.92	N/A	N/A	N/A
LNAI	LUNAI BIOWORKS INC	$10.88M	N/A	-1,617.80%	1,355.58%	749.20%	-2.03	0.19	100.00%	-612,568.10%	-609,894.27%
XENE	XENON PHARMACEUTICALS INC	$6.12B	-44.00%	-41.70%	-32.87%	-58.30%	0.04	21.02	N/A	N/A	N/A
CVKD	CADRENAL THERAPEUTICS INC	$5.56M	-411.00%	-275.60%	-661.53%	1,138.50%	0.59	2.68	N/A	N/A	N/A
PMN	PROMIS NEUROSCIENCES INC	$134.25M	-238.00%	-151.00%	-66.81%	761.30%	0.11	9.92	N/A	N/A	N/A
BCDA	BIOCARDIA INC	$10.60M	-5,456.10%	-232.70%	729.36%	502.30%	-2.61	0.41	N/A	N/A	N/A
VERU	VERU INC	$47.57M	-45.90%	-34.60%	-44.08%	-365.60%	0.31	4.42	N/A	N/A	N/A
CDT	CDT EQUITY INC	$1.87M	-145.30%	-103.30%	-36.36%	-149.00%	0.21	0.14	N/A	N/A	N/A
MBX	MBX BIOSCIENCES INC	$3.18B	-26.00%	-24.90%	-25.30%	-34.30%	0.06	18.08	N/A	N/A	N/A
PLYX	POLARYX THERAPEUTICS INC	$104.16M	N/A	N/A	N/A	N/A	0.41	3.45	N/A	N/A	N/A
ACHV	ACHIEVE LIFE SCIENCES INC	$695.00M	-193.50%	-111.90%	-240.13%	-362.20%	2.10	2.63	N/A	N/A	N/A
NBP	NOVABRIDGE BIOSCIENCES	$212.41M	-20.90%	-19.40%	-19.80%	-73.60%	0.13	8.09	N/A	N/A	N/A
GANX	GAIN THERAPEUTICS INC	$87.87M	-201.40%	-136.20%	-136.66%	1,668.10%	0.34	4.69	N/A	N/A	N/A
EVMN	EVOMMUNE INC	$515.71M	-62.60%	-40.50%	-33.28%	-53.20%	0.09	11.68	100.00%	-946.70%	-946.68%
KYTX	KYVERNA THERAPEUTICS INC	$487.58M	-81.90%	-64.90%	-68.29%	-95.20%	0.31	8.15	N/A	N/A	N/A
BTAI	BIOXCEL THERAPEUTICS INC	$28.78M	N/A	-201.50%	277.29%	-78.80%	-1.32	0.62	36.30%	-11,078.50%	-8,550.74%
RZLT	REZOLUTE INC	$444.87M	-58.80%	-54.50%	-69.20%	-74.40%	0.07	15.84	N/A	N/A	N/A
ARTL	ARTELO BIOSCIENCES INC	$1.74M	-1,602.50%	-225.00%	-195.28%	324.80%	0.88	1.79	N/A	N/A	N/A
LABT	LAKEWOOD-AMEDEX BIOTHERAPEUTICS INC	$1.65M	N/A	N/A	N/A	N/A	-1.07	0.02	N/A	N/A	N/A
NGNE	NEUROGENE INC	$565.71M	-37.90%	-34.70%	-40.38%	-52.40%	0.11	13.08	N/A	N/A	N/A
TRVI	TREVI THERAPEUTICS INC	$2.54B	-23.60%	-22.60%	-15.90%	-28.40%	0.03	37.28	N/A	N/A	N/A
DBVT	DBV TECHNOLOGIES SA	$834.30M	-119.30%	-84.40%	-103.74%	3,499.70%	0.39	3.72	100.00%	-3,506.50%	-3,491.11%
ORKA	ORUKA THERAPEUTICS INC	$6.93B	-20.80%	-20.10%	-11.90%	-25.10%	0.02	38.51	N/A	N/A	N/A
BDTX	BLACK DIAMOND THERAPEUTICS INC	$120.08M	-38.80%	-30.50%	-38.97%	-37.80%	0.30	7.28	N/A	N/A	N/A
NXTC	NEXTCURE INC	$30.81M	-175.50%	-113.70%	-263.76%	-252.10%	0.86	3.47	N/A	N/A	N/A
PYXS	PYXIS ONCOLOGY INC	$179.30M	-135.60%	-85.00%	-168.21%	-96.30%	1.06	2.76	82.80%	-589.80%	-579.80%
STOK	STOKE THERAPEUTICS INC	$2.13B	-59.40%	-51.50%	-63.39%	-89.30%	0.14	7.69	100.00%	-753.60%	-808.90%
QCLS	Q/C TECHNOLOGIES INC	$22.70M	-93.90%	-43.60%	-33.94%	-246.60%	0.71	3.72	N/A	N/A	N/A
ZBIO	ZENAS BIOPHARMA INC	$2.05B	-167.70%	-97.40%	-59.88%	-161.80%	1.23	11.94	N/A	N/A	N/A
TLSA	TIZIANA LIFE SCIENCES LTD	$121.71M	-924.30%	-161.80%	-6,444.41%	1,249.60%	220.06	0.76	N/A	N/A	N/A
TSHA	TAYSHA GENE THERAPIES INC	$1.92B	-56.10%	-40.20%	-46.32%	-220.10%	0.42	14.04	100.00%	-1,738.40%	-1,737.69%
DFTX	DEFINIUM THERAPEUTICS INC	$5.50B	-85.20%	-64.60%	-36.49%	-198.20%	0.21	6.95	N/A	N/A	N/A
ODTX	ODYSSEY THERAPEUTICS INC	$977.99M	N/A	N/A	N/A	N/A	0.15	11.36	N/A	N/A	N/A
ONCO	ONCONETIX INC	$1.11M	-109.00%	-51.10%	-77.94%	128.70%	0.26	1.41	79.60%	-1,364.20%	-1,247.44%
SRRK	SCHOLAR ROCK HOLDING CORP	$6.34B	-160.20%	-87.20%	-88.17%	-209.20%	1.06	7.02	N/A	N/A	N/A
BNTX	BIONTECH SE	$23.47B	-9.10%	-8.00%	-8.60%	-18.40%	0.15	7.85	75.50%	-63.60%	-59.68%
COYA	COYA THERAPEUTICS INC	$112.59M	-57.30%	-50.10%	-42.48%	1,962.90%	0.09	15.02	100.00%	-266.10%	-266.07%
ANNX	ANNEXON INC	$874.92M	-102.10%	-76.70%	-86.57%	-215.60%	0.29	6.35	N/A	N/A	N/A
SGMT	SAGIMET BIOSCIENCES INC	$582.47M	-37.60%	-35.50%	-42.47%	-54.90%	0.05	20.34	N/A	N/A	N/A
FULC	FULCRUM THERAPEUTICS INC	$281.54M	-28.50%	-27.20%	-27.10%	-38.50%	0.04	31.35	N/A	N/A	N/A
BHVN	BIOHAVEN LTD	$2.18B	-866.50%	-138.00%	-156.05%	-152.70%	2.60	7.41	N/A	N/A	N/A
ARCT	ARCTURUS THERAPEUTICS HOLDINGS INC	$213.74M	-46.50%	-36.50%	-48.90%	-375.40%	0.31	5.88	100.00%	-317.60%	-317.64%
ABEO	ABEONA THERAPEUTICS INC	$421.76M	41.40%	29.50%	41.69%	57.30%	0.37	5.89	70.90%	454.90%	480.13%
GLSI	GREENWICH LIFESCIENCES INC	$228.25M	-941.10%	-368.50%	-412.83%	605.70%	0.99	2.01	N/A	N/A	N/A
UNCY	UNICYCIVE THERAPEUTICS INC	$133.50M	-131.20%	-82.30%	-105.20%	2,005.20%	0.71	2.40	N/A	N/A	N/A
IONS	IONIS PHARMACEUTICALS INC	$9.21B	-110.90%	-17.40%	-17.64%	-11.60%	5.81	7.89	98.20%	-64.70%	-54.06%
PVLA	PALVELLA THERAPEUTICS INC	$2.22B	-47.80%	-38.30%	-21.80%	-242.00%	0.17	21.18	N/A	N/A	N/A
CABA	CABALETTA BIO INC	$454.92M	-131.60%	-96.50%	-162.31%	-279.90%	0.43	2.95	N/A	N/A	N/A
CLNN	CLENE INC	$55.84M	N/A	-159.10%	-205.21%	-111.30%	-2.15	1.94	82.80%	-25,009.70%	-22,871.64%
LRMR	LARIMAR THERAPEUTICS INC	$447.74M	-137.40%	-97.70%	-131.62%	-823.00%	0.30	4.70	N/A	N/A	N/A
VRXA	VERAXA BIOTECH HOLDING AG	$267.26M	N/A	-20.00%	-90.29%	-20.20%	-6.13	0.44	66.00%	-284,359.20%	-286,029.75%
BCTX	BRIACELL THERAPEUTICS CORP	$30.01M	-155.10%	-130.60%	-134.00%	-411.10%	0.16	7.07	N/A	N/A	N/A
KLRS	KALARIS THERAPEUTICS INC	$94.46M	-72.80%	-43.50%	-43.35%	-155.90%	0.60	12.19	N/A	N/A	N/A
LXRX	LEXICON PHARMACEUTICALS INC	$1.08B	-40.40%	-26.90%	-22.41%	-33.70%	0.43	13.37	99.10%	-147.40%	-127.16%
LBRX	LB PHARMACEUTICALS INC	$1.30B	N/A	N/A	N/A	N/A	0.04	35.68	N/A	N/A	N/A
OCS	OCULIS HOLDING AG	$866.19M	-42.70%	-35.30%	-35.32%	-68.60%	0.14	8.35	100.00%	-6,604.80%	-6,552.71%
CELC	CELCUITY INC	$4.30B	-244.60%	-50.20%	-45.85%	-34.30%	6.66	12.31	N/A	N/A	N/A
CRVS	CORVUS PHARMACEUTICALS INC	$1.24B	-36.10%	-33.60%	-23.99%	-40.30%	0.06	16.16	N/A	N/A	N/A
SPRY	ARS PHARMACEUTICALS INC	$590.85M	-153.60%	-60.80%	-81.11%	-52.70%	3.69	4.94	74.10%	-200.00%	-194.99%
IMRX	IMMUNEERING CORP	$310.55M	-27.20%	-25.70%	-29.53%	-57.40%	0.06	19.47	N/A	N/A	N/A
AURA	AURA BIOSCIENCES INC	$831.23M	-78.10%	-64.10%	-92.83%	-112.10%	0.28	7.09	N/A	N/A	N/A
ZURA	ZURA BIO LTD	$528.19M	-76.80%	-65.90%	-34.39%	568.20%	0.05	19.33	N/A	N/A	N/A
PCVX	VAXCYTE INC	$8.81B	-37.60%	-33.60%	-37.12%	-37.80%	0.14	5.72	N/A	N/A	N/A
GNLX	GENELUX CORP	$118.83M	-174.60%	-123.60%	-133.79%	-207.60%	0.41	3.68	N/A	N/A	N/A
ACRV	ACRIVON THERAPEUTICS INC	$74.05M	-64.40%	-57.10%	-79.84%	-89.80%	0.13	8.98	N/A	N/A	N/A
ATOS	ATOSSA THERAPEUTICS INC	$23.55M	-103.00%	-85.80%	-140.55%	3,053.40%	0.20	5.69	N/A	N/A	N/A
ALMS	ALUMIS INC	$3.23B	-54.60%	-43.50%	-40.95%	-67.30%	0.18	7.51	100.00%	-2,825.70%	-2,927.59%
HUMA	HUMACYTE INC	$157.63M	-2,781.60%	-85.40%	-92.26%	-80.30%	8.51	3.93	-475.00%	-4,840.80%	-4,318.95%
SPRB	SPRUCE BIOSCIENCES INC	$127.73M	-155.40%	-101.70%	-82.16%	1,096.50%	0.62	4.67	N/A	N/A	N/A
ACTU	ACTUATE THERAPEUTICS INC	$24.17M	-430.90%	-180.90%	-513.59%	372.90%	1.36	1.80	N/A	N/A	N/A
RNXT	RENOVORX INC	$51.86M	-138.60%	-104.60%	-101.87%	2,924.70%	0.24	7.15	78.70%	-824.00%	-823.98%
IMNM	IMMUNOME INC	$2.97B	-51.20%	-47.30%	-37.91%	-669.90%	0.05	21.68	100.00%	-5,593.80%	-5,593.85%
CNTN	CANTON STRATEGIC HOLDINGS INC	$132.63M	-36.90%	-29.00%	-15.61%	-35.10%	0.24	37.75	N/A	N/A	N/A
MTVA	METAVIA INC	$9.36M	-209.70%	-107.90%	-208.61%	258.70%	0.95	2.06	N/A	N/A	N/A
LITS	LITE STRATEGY INC	$30.66M	-90.80%	-89.30%	-107.01%	-108.90%	0.02	11.53	N/A	N/A	N/A
IMVT	IMMUNOVANT INC	$8.45B	-69.60%	-62.50%	-73.28%	1,761.00%	0.16	7.27	N/A	N/A	N/A
ORIC	ORIC PHARMACEUTICALS INC	$1.42B	-35.40%	-33.40%	-36.56%	-39.70%	0.06	13.19	N/A	N/A	N/A
RVMD	REVOLUTION MEDICINES INC	$44.06B	-96.40%	-63.20%	-43.06%	-66.30%	0.66	11.38	N/A	N/A	N/A
AVIR	ATEA PHARMACEUTICALS INC	$404.14M	-57.00%	-51.50%	-75.24%	-81.10%	0.14	7.89	N/A	N/A	N/A
AMLX	AMYLYX PHARMACEUTICALS INC	$2.63B	-52.90%	-48.50%	-62.46%	-133.20%	0.11	12.12	N/A	N/A	N/A
SABS	SAB BIOTHERAPEUTICS INC	$342.11M	-6.70%	-6.10%	-5.54%	-6.60%	0.11	9.22	N/A	N/A	N/A
GPCR	STRUCTURE THERAPEUTICS INC	$3.71B	-16.90%	-16.10%	-15.75%	-23.50%	0.05	20.75	N/A	N/A	N/A
JBIO	JADE BIOSCIENCES INC	$1.42B	-49.10%	-45.60%	-34.76%	-64.30%	0.07	14.93	N/A	N/A	N/A

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Aug 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the #1 top biotech stock out of 613 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Puma Biotechnology (NASDAQ:PBYI) is: Value: A, Growth: C, Momentum: B, Sentiment: A, Safety: C, Financials: A, and AI: C.

Puma Biotechnology (NASDAQ:PBYI) has a Due Diligence Score of 45, which is 21 points higher than the biotech industry average of 24.

PBYI passed 14 out of 33 due diligence checks and has strong fundamentals. Puma Biotechnology has seen its stock return 80.82% over the past year, overperforming other biotech stocks by 88 percentage points.

Puma Biotechnology has an average 1 year price target of $6.00, a downside of -31.58% from Puma Biotechnology's current stock price of $8.77.

Puma Biotechnology stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Puma Biotechnology, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Immucell (NASDAQ:ICCC)

Immucell (NASDAQ:ICCC) is the #2 top biotech stock out of 613 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Immucell (NASDAQ:ICCC) is: Value: C, Growth: A, Momentum: B, Sentiment: C, Safety: C, Financials: B, and AI: C.

Immucell (NASDAQ:ICCC) has a Due Diligence Score of 19, which is -5 points lower than the biotech industry average of 24. Although this number is below the industry average, our proven quant model rates ICCC as a "A".

ICCC passed 6 out of 33 due diligence checks and has weak fundamentals. Immucell has seen its stock return 64.41% over the past year, overperforming other biotech stocks by 71 percentage points.

3. Corcept Therapeutics (NASDAQ:CORT)

Corcept Therapeutics (NASDAQ:CORT) is the #3 top biotech stock out of 613 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Corcept Therapeutics (NASDAQ:CORT) is: Value: B, Growth: A, Momentum: B, Sentiment: B, Safety: C, Financials: B, and AI: C.

Corcept Therapeutics (NASDAQ:CORT) has a Due Diligence Score of 50, which is 26 points higher than the biotech industry average of 24.

CORT passed 17 out of 33 due diligence checks and has strong fundamentals. Corcept Therapeutics has seen its stock return 55.43% over the past year, overperforming other biotech stocks by 62 percentage points.

Corcept Therapeutics has an average 1 year price target of $122.60, an upside of 9.6% from Corcept Therapeutics's current stock price of $111.86.

Corcept Therapeutics stock has a consensus Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Corcept Therapeutics, 60% have issued a Strong Buy rating, 20% have issued a Buy, 0% have issued a hold, while 20% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 7 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 31.05%, which is 26 percentage points higher than the biotech industry average of 5.37%.

Dominari Holdings's dividend payout ratio of -19.1% indicates that its high dividend yield might not be sustainable for the long-term.

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

Oramed Pharmaceuticals (NASDAQ:ORMP) has an annual dividend yield of 5.88%, which is 1 percentage points higher than the biotech industry average of 5.37%.

Oramed Pharmaceuticals's dividend payout ratio of 5.9% indicates that its high dividend yield is sustainable for the long-term.

3. Novo Nordisk (Ozempic) (NYSE:NVO)

Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 2.7%, which is -3 percentage points lower than the biotech industry average of 5.37%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% nine times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 46.1% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks down?

Biotech stocks were down -0.12% in the last day, and up 3.4% over the last week. Pds Biotechnology was the among the top losers in the biotechnology industry, dropping -64.84% yesterday.

PDS Biotechnology shares are trading lower after the company issued CEO letter outlining plans to advance PDS0301 and pursue partnerships for PDS0101 after ceasing internal investment in its Phase 3 study.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Exelixis (NASDAQ:EXEL)

Exelixis (NASDAQ:EXEL) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Exelixis has a valuation score of 14, which is 1 points higher than the biotech industry average of 13. It passed 1 out of 7 valuation due diligence checks.

Exelixis's stock has gained 37.21% in the past year. It has overperformed other stocks in the biotech industry by 44 percentage points.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 43, which is 30 points higher than the biotech industry average of 13. It passed 3 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 13.56% in the past year. It has overperformed other stocks in the biotech industry by 20 percentage points.

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Jazz Pharmaceuticals has a valuation score of 57, which is 44 points higher than the biotech industry average of 13. It passed 4 out of 7 valuation due diligence checks.

Jazz Pharmaceuticals's stock has gained 123.91% in the past year. It has overperformed other stocks in the biotech industry by 131 percentage points.

Are biotech stocks a good buy now?

68.09% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 48.53% over the next year.

3.46% of biotech stocks have a Zen Rating of A (Strong Buy), 4.11% of biotech stocks are rated B (Buy), 41.77% are rated C (Hold), 38.96% are rated D (Sell), and 11.69% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 16.08x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Puma Biotechnology (NASDAQ:PBYI)

2. Immucell (NASDAQ:ICCC)

3. Corcept Therapeutics (NASDAQ:CORT)

1. Dominari Holdings (NASDAQ:DOMH)

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

3. Novo Nordisk (Ozempic) (NYSE:NVO)

1. Exelixis (NASDAQ:EXEL)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2026)Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Puma Biotechnology (NASDAQ:PBYI)

2. Immucell (NASDAQ:ICCC)

3. Corcept Therapeutics (NASDAQ:CORT)

1. Dominari Holdings (NASDAQ:DOMH)

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

3. Novo Nordisk (Ozempic) (NYSE:NVO)

1. Exelixis (NASDAQ:EXEL)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.